{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:11:18Z","timestamp":1790226678103,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1016\/s0302-2838(03)00357-9","type":"journal-article","created":{"date-parts":[[2003,7,31]],"date-time":"2003-07-31T23:44:52Z","timestamp":1059695092000},"page":"429-434","source":"Crossref","is-referenced-by-count":252,"title":["Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial"],"prefix":"10.1016","volume":"44","author":[{"given":"Adrian P.M.","family":"van der Meijden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Oosterlinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hoeltl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo V.","family":"Bono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0302-2838(03)00357-9_BIB1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-5347(05)64043-8","article-title":"Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity","volume":"169","author":"Bohle","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/S0302-2838(03)00357-9_BIB2","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/S0302-2838(03)00357-9_BIB3","unstructured":"Lamm DL, Steg A, Boccon-Gibod L, Morales A, Hanna Jr MG, Pagano F, et al. Complications of bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complications. Prog Clin Biol Res 1989;335\u201355."},{"key":"10.1016\/S0302-2838(03)00357-9_BIB4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","article-title":"Incidence and treatment of complications of bacillus Calmette-Gu\u00e9rin intravesical therapy in superficial bladder cancer","volume":"47","author":"Lamm","year":"1992","journal-title":"J. Urol."},{"key":"10.1016\/S0302-2838(03)00357-9_BIB5","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of intravesical doxorubicin and immunotherapy with bacillus Calmette-Gu\u00e9rin for transitional cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/S0302-2838(03)00357-9_BIB6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0022-5347(05)65966-6","article-title":"Intravesical instillation of epirubicin, bacillus Calmette-Guerin, and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder. A European Organization for Research and Treatment of Cancer GU Group randomized phase III trial","volume":"166","author":"van der Meijden","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/S0302-2838(03)00357-9_BIB7","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Gu\u00e9rin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study","volume":"163","author":"Lamm","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/S0302-2838(03)00357-9_BIB8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0022-5347(01)64936-X","article-title":"Does isoniazid reduce side effects of intravesical bacillus Calmette-Gu\u00e9rin therapy in superficial bladder cancer? Interim results of EORTC protocol 30911","volume":"157","author":"Vegt","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/S0302-2838(03)00357-9_BIB9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1464-410x.2001.02306.x","article-title":"A systematic review of intravesical bacillus Calmette-Guerin plus transurethral resection versus transurethral resection alone in Ta and T1 bladder cancer","volume":"88","author":"Shelley","year":"2001","journal-title":"BJU Int."},{"key":"10.1016\/S0302-2838(03)00357-9_BIB10","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0022-5347(01)65396-5","article-title":"A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer","volume":"156","author":"Pawinski","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/S0302-2838(03)00357-9_BIB11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/1561095021000037631","article-title":"Use of BCG in immunotherapy of superficial bladder cancer: multicentric investigation on safety and compliance","volume":"2","author":"Morgia","year":"2002","journal-title":"UroOncology"},{"key":"10.1016\/S0302-2838(03)00357-9_BIB12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0090-4295(00)01117-1","article-title":"Tolerability of bacille Calmette-Guerin maintenance therapy for superficial bladder cancer","volume":"57","author":"Saint","year":"2001","journal-title":"Urology"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283803003579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283803003579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T07:53:42Z","timestamp":1552809222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283803003579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S0302283803003579"],"URL":"https:\/\/doi.org\/10.1016\/s0302-2838(03)00357-9","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}